Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors ...
Jun 14, 2025
0
0
JoEllen Zembruski-Ruple, while in the care of New York City's renowned Memorial Sloan Kettering Cancer Center, swallowed the first three chemotherapy pills to treat her squamous cell carcinoma on Jan. 29, her family members ...
Jun 9, 2025
0
1
One in five Americans is likely to get skin cancer in their lifetime, making it the most common type of cancer in the U.S. But the good news is that it's highly treatable when caught early, especially if it can be treated ...
May 28, 2025
0
1
Immunotherapies are undoubtedly transforming the landscape of cancer treatment worldwide. By harnessing the body's immune system to fight disease, they can achieve outcomes in advanced cancers that are impossible with conventional ...
May 27, 2025
0
0
Researchers at the First Affiliated Hospital of Chongqing Medical University in China have uncovered a sharply rising burden of skin cancer in older adults driven largely by population growth and affecting men twice as often.
For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical hysterectomy (MRH) or radical hysterectomy (RH), according to a study published online May 15 in JAMA ...
May 21, 2025
0
0
The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered in a new study in mice and humans by researchers at UCL, the Wellcome Sanger Institute and the ...
May 1, 2025
0
82
Pembrolizumab (Keytruda) given before and after surgery to supplement adjuvant therapy improved responses and survival in patients with previously untreated, locally advanced head and neck squamous cell carcinoma (HNSCC), ...
Apr 29, 2025
0
0
Skin cancer is the most common cancer in the United States and a significant health issue, with millions of non-melanoma cases and tens of thousands of melanomas diagnosed annually. Furthermore, treating skin cancer costs ...
Mar 12, 2025
0
0
Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year, with one in five cases occurring in people younger than 55, according ...
Feb 26, 2025
0
13
Squamous cell carcinoma (SCC or SqCC) is a form of skin cancer. Skin cancers fall into two groups, melanoma and non-melanoma; squamous cell carcinoma is a non-melanoma cancer. It is one of the most common cancers in humans and other animals.
Squamous cells are a type of epithelium cell forming the outermost layers of the skin and some organs in the body. Squamous cell carcinoma usually occurs on the skin, especially portions commonly exposed to the Sun, the face, ears, neck, hands, or arm. The main symptom is a growing bump that may have a rough, scaly surface and flat reddish patches. It may also occur inside the body wherever squamous cells are found, including the esophagus, urinary bladder, prostate, lung, vagina, and cervix, among others.
Despite the common name, squamous cell carcinomas arising in different body sites can show tremendous differences in their presenting signs and symptoms, natural history, prognosis, and response to treatment.
Though the use of these terms has been decreasing in the literature, SqCC is still sometimes referred to as "epidermoid carcinoma" and "squamous cell epithelium". During its earliest stages, it is sometimes known as "Bowen's disease".
This text uses material from Wikipedia licensed under CC BY-SA
